You Position: Home > Paper
Application of pimecrolimus in the treatment of allergic dermatoses such as dermatitis and eczema
( views:400, downloads:252 )
- Author:
- No author available
- Journal Title:
- INTERNATIONAL JOURNAL OF DERMATOLOGY AND VENEREOLOGY
- Issue:
- 4
- DOI:
- 10.3760/cma.j.issn.1673-4173.2011.04.013
- Key Word:
- 特应性皮炎;湿疹;吡美莫司;Atopic dermatitis;Eczema;Pimecrolimus
Abstract： As a new type of topical immunosuppressive agent,pimecrolimus is mainly used in the treatment of atopic dermatitis.Recently,the application range of pimecrolimus has been broadened and it has been widely used in many allergic dermatoses,such as atopic dermatitis,eczema,contact dermatitis,perioral dermatitis,et al.Several clinical studies have suggested that topical pimecrolimus twice daily has favorable effect with few side effects.Therefore,pimecrolimus may have a promising future in the treatment of allergic dermatoses such as dermatitis and eczema.
- [1]Funda, Schurmeyer-Horst,Thomas A, Luger,Markus, Bohm.Long-term efficacy of occlusive therapy with topical pimecrolimus in severe dyshidrosiform hand and foot eczema.[J].2007,214(1).
- [2]Lin AN.Innovative use of topical calcineurin inhibitors.[J].2010,28(3).
- [3]Schwarz T,Kreiselmaier I,Bieber T,etc.A randomized, double-blind, vehicle-controlled study of 1; pimecrolimus cream in adult patients with perioral dermatitis.[J].2008,59(1).
- [4]Daniel N, Sauder.Mechanism of action and emerging role of immune response modifier therapy in dermatologic conditions.[J].2004,8 Suppl 3.
- [5]Bunselmeyer B,Brautigam M,Schulz P,etc.Pimecrolimus cream 1% is effective in asteatotic eczema: results of a randomized, double-blind, vehicle-controlled study in 40 patients.[J].2007,21(1).
- [6]Mensing CH,Mensing CO,Mensing H.Treatment with pimecrolimus cream 1% clears irritant dermatitis of the periocular region, face and neck.[J].2008,47(9).
- [7]Emel, Erkek,Mustafa, Kazkayasi,Onder, Bozdogan.Acute actinic cheilitis-like chemical irritant reaction following accidental contact with ethylene glycol-favorable response to topical 1% pimecrolimus cream: a case report.[J].2008,27(2).
- [8]Salgo R,Thaci D.Malignancy concerns of topical calcineurin inhibitors for atopic dermatitis: facts and controversies.[J].2010,28(1).
- [9]Neczyporenko F,Blondeel A.Allergic contact dermatitis to Elidel cream itself?[J].2010,63(3).
- [10]Mashaly HM,Hafez VS,El Batawy MM,etc.Topical calcineurin inhibitors in atopic dermatitis: a systematic review and meta-analysis.[J].2009,54(2).
- [11]Donald V, Belsito,Joseph F, Fowler,James G, Marks,etc.Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis.[J].2004,73(1).
- [12]Kekki OM,Hultsch T,Ruer Mulard M,etc.Twice-daily versus once-daily applications of pimecrolimus cream 1% for the prevention of disease relapse in pediatric patients with atopic dermatitis.[J].2009,26(5).
- [13]Brautigam M,Pavicic T,Wollenberg A,etc.Pimecrolimus cream (1%) efficacy in perioral dermatitis - results of a randomized, double-blind, vehicle-controlled study in 40 patients.[J].2007,21(9).
- [14]Iqbal A, Bukhari.Successful treatment of chronic persistent vesicular hand dermatitis with topical pimecrolimus.[J].2005,26(12).
- [15]Leung DY,Pariser DM,Hanifin JM.Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trial.[J].2009,161(2).
- [16]Di Costanzo L,Balato N,Zagaria O,etc.Successful management of a delayed and persistent cutaneous reaction to jellyfish with pimecrolimus.[J].2009,20(3).
- [17]Wang,F.-S.,Yan,J.,Chen,S.-L..Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: A meta-analysis of randomized clinical trials[J].2010,21(3).
- [18]Hultsch T,Kapp A,Spergel J.Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.[J].2005,211(2).
- [19]Eichenfield,L.F.,Werfel,T.,Ho,V.,etc.Addition of pimecrolimus cream 1% to a topical corticosteroid treatment regimen in paediatric patients with severe atopic dermatitis: A randomized, double-blind trial[J].2010,21(3).
- [20]Kwong KY,Paek D,Tovar JP,etc.Pimecrolimus induces apoptosis of mast cells in a murine model of cutaneous mastocytosis.[J].2010,153(4).